3DBio Therapeutics
Nathaniel Bachrach, Ph.D., is Chief Scientific Officer and Executive Vice President of 3DBio Therapeutics. Prior to 3DBio, Nathaniel was the Vice President of Research & Technology at LifeCell (NASDAQ: LIFC), which was acquired by Allergan. Nathaniel came to LifeCell from Organogenesis. Dr. Bachrach received his Ph.D., as well as B.S. and M.S. degrees, in Mechanical Engineering from Columbia University in New York, where his research focused on cartilage and regenerative medicine.
This person is not in any offices
3DBio Therapeutics
3DBio Therapeutics is a biologics and bioprinting company with a focus on regenerative medicine that precision manufactures living tissues to allow the replacement of each individual patient’s parts with tissues designed and created specifically for them. 3DBio has developed unique capabilities toward the creation of living tissue implants for therapeutic applications.